Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source
twitter: 11 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Enzyme Replacement Therapy for the Treatment of Gaucher Disease Type 1: Clinical Effectiveness

Cited by Canadian Agency for Drugs and Technologies in Health on 15 Dec 2017

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.